Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HTGMQ NASDAQ:STAI NASDAQ:TBIO NASDAQ:THMO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHTGMQHTG Molecular Diagnostics$0.00$0.00▼$0.00N/A3.061,989 shsN/ASTAIScanTech AI Systems$0.00+50.0%$0.12$0.00▼$30.80$2K0.4292,341 shs3,158 shsTBIOTelesis Bio$0.00$0.01$0.00▼$0.15$2K2.431,429 shsN/ATHMOThermoGenesis$0.00$0.00▼$0.00$1K1.11,091 shs7 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHTGMQHTG Molecular Diagnostics0.00%0.00%0.00%0.00%0.00%STAIScanTech AI Systems0.00%-99.25%-99.65%-99.50%-100.00%TBIOTelesis Bio0.00%-89.00%+10.00%-98.00%-95.00%THMOThermoGenesis0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHTGMQHTG Molecular Diagnostics$0.00$0.00▼$0.00N/A3.061,989 shsN/ASTAIScanTech AI Systems$0.00+50.0%$0.12$0.00▼$30.80$2K0.4292,341 shs3,158 shsTBIOTelesis Bio$0.00$0.01$0.00▼$0.15$2K2.431,429 shsN/ATHMOThermoGenesis$0.00$0.00▼$0.00$1K1.11,091 shs7 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHTGMQHTG Molecular Diagnostics0.00%0.00%0.00%0.00%0.00%STAIScanTech AI Systems0.00%-99.25%-99.65%-99.50%-100.00%TBIOTelesis Bio0.00%-89.00%+10.00%-98.00%-95.00%THMOThermoGenesis0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHTGMQHTG Molecular Diagnostics 0.00N/AN/AN/ASTAIScanTech AI Systems 1.00SellN/AN/ATBIOTelesis Bio 0.00N/AN/AN/ATHMOThermoGenesis 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHTGMQHTG Molecular Diagnostics$6.37M0.00N/AN/AN/ANaNSTAIScanTech AI Systems$1.88M0.00N/AN/A($824.77) per share0.00TBIOTelesis Bio$225.09M0.00N/AN/A$0.14 per share0.01THMOThermoGenesis$9.61M0.00N/AN/A($0.99) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHTGMQHTG Molecular Diagnostics-$21.59M-$2.28N/AN/AN/AN/AN/AN/AN/ASTAIScanTech AI Systems-$23.07M-$9.20N/AN/AN/A-477.09%-11.25%209.23%N/ATBIOTelesis Bio-$47.72M-$20.52N/AN/AN/A-336.59%N/A-61.89%8/6/2026 (Estimated)THMOThermoGenesis-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/ALatest TBIO, STAI, THMO, and HTGMQ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026N/ATBIOTelesis Bio-$6.39N/AN/AN/A$2.53 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/AN/ASTAIScanTech AI SystemsN/AN/AN/AN/AN/ATBIOTelesis BioN/AN/AN/AN/AN/ATHMOThermoGenesisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHTGMQHTG Molecular DiagnosticsN/AN/AN/ASTAIScanTech AI SystemsN/A0.180.12TBIOTelesis BioN/A1.231.06THMOThermoGenesisN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHTGMQHTG Molecular DiagnosticsN/ASTAIScanTech AI Systems74.04%TBIOTelesis Bio37.63%THMOThermoGenesis5.78%Insider OwnershipCompanyInsider OwnershipHTGMQHTG Molecular Diagnostics2.60%STAIScanTech AI Systems2.33%TBIOTelesis Bio24.50%THMOThermoGenesis78.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHTGMQHTG Molecular Diagnostics902.21 million2.16 millionNot OptionableSTAIScanTech AI SystemsN/A5.88 million3.67 millionN/ATBIOTelesis Bio2001.80 million1.36 millionNo DataTHMOThermoGenesis407.95 million1.75 millionNot OptionableTBIO, STAI, THMO, and HTGMQ HeadlinesRecent News About These CompaniesCitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical StudiesFebruary 19, 2026 | globenewswire.comTHMO | ThermoGenesis Holdings Inc. Annual Cash Flow Statement | MarketWatchJuly 29, 2025 | marketwatch.comThe Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat LossMarch 10, 2025 | globenewswire.comIce Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight LossFebruary 20, 2025 | globenewswire.comNorth American Morning Briefing: Stock Futures, -2-September 19, 2024 | morningstar.comMIs Thermogenesis Holdings Inc Stock (THMO) a Good Investment?August 8, 2024 | aaii.comAThermoGenesis Holdings (OTC:THMO) Stock Quotes, Forecast and News SummaryJuly 28, 2024 | benzinga.comThermoGenesis Holdings (OTC:THMO) Stock, Short Interest ReportJuly 28, 2024 | benzinga.comWhy Is ThermoGenesis (THMO) Stock Down 37% Today?June 12, 2024 | investorplace.comTHMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024May 17, 2024 | investorplace.comThermoGenesis Holdings, Inc. (NASDAQ:THMO) Is About To Turn The CornerFebruary 27, 2024 | finance.yahoo.comThermoGenesis Holdings, Inc.January 9, 2024 | thestreet.comThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and DatesDecember 16, 2023 | benzinga.comShareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time BeingDecember 8, 2023 | finance.yahoo.comThermoGenesis Holdings Recent Insider ActivityNovember 21, 2023 | benzinga.comThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 15, 2023 | finanznachrichten.deThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comThermoGenesis Q3 Earnings PreviewNovember 12, 2023 | msn.comHere's what Wall Street expects from ThermoGenesis's earnings reportNovember 12, 2023 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026SanDisk’s Volatility May Be Telling Bulls What They Want to HearBy Sam Quirke | July 2, 2026KBR Insiders Are Buying While the Market Misreads Its SpinoffBy Thomas Hughes | July 6, 2026GE Sparks a High-Voltage Aviation BreakoutBy Jeffrey Neal Johnson | July 22, 2026IBM Just Had Its Worst Day Ever—What Earnings Must ProveBy Chris Markoch | July 21, 2026TBIO, STAI, THMO, and HTGMQ Company DescriptionsHTG Molecular Diagnostics NASDAQ:HTGMQHTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.ScanTech AI Systems NASDAQ:STAI$0.0006 +0.00 (+50.00%) As of 07/24/2026 11:39 AM EasternScantech AI Systems, Inc. engages in the innovation, emerging technology, and machine learning expertise. ScanTech specializes in developing advanced screening technology that provides the most accurate and fastest detection of prohibited materials. The company was founded on September 5, 2023 and is headquartered in Buford, GA.Telesis Bio NASDAQ:TBIO$0.0011 0.00 (0.00%) As of 07/24/2026Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.ThermoGenesis NASDAQ:THMOThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier AMD and Cerbras Create A New Blueprint For Hardware Intel Earnings Reveal Whether the Chip Selloff Created a Buy CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test Defense Earnings Show Readiness Now and Modernization Ahead Freeport McMoRan Post-Earnings: Why Good Enough May Finally Be Good Enough Tesla Just Delivered Record Sales—So Why Did the Stock Sell Off? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
